| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Chief Medical Officer
1 company
Ticho Barry is a Chief Medical Officer at STOK. Recent filings cover 0 purchases and 60 sales. Those positions are worth an estimated $668K at current prices.
Our model assigns Ticho Barry a middling insider score of 50/100, based on 43 past trades. Over a 12-month horizon, 34.4% of those trades were profitable, with an average 12-month return of -29.4%.
Ticho Barry's largest disclosed position is in STOK as Chief Medical Officer, worth about $668K. The recent filings there lean toward selling, a net 378,174 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 3, 2023 | STOK Stoke Therapeutics, Inc. | Chief Medical Officer | Sell | 55,177 | $10.06 | $555,267.07 | -19.7% | -32.8% | +23.2% | |
| Feb 6, 2023 | STOK Stoke Therapeutics, Inc. | Chief Medical Officer | Sell | 12,998 | $10.02 | $130,236.44 | -5.3% | +26.7% | -50.4% | |
| Feb 2, 2023 | STOK Stoke Therapeutics, Inc. | Chief Medical Officer | Sell | 6,172 | $10.01 | $61,810.14 | -1.6% | -4.9% | -53.4% | |
| Jul 13, 2021 | STOK Stoke Therapeutics, Inc. | Chief Medical Officer | Sell | 43,166 | $32.75 | $1,413,654.08 | -14.0% | -29.4% | -54.3% | |
| Dec 21, 2020 | STOK Stoke Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 1,365 | $57.62 | $78,654.05 | -0.3% | - | - | |
| Jun 1, 2020 | STOK Stoke Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 1,365 | $27.39 | $37,386.70 | -0.4% | - | - |